Quantitative proteomics suggests decrease in the secretogranin‐1 cerebrospinal fluid levels during the disease course of multiple sclerosis

By  

PROTEOMICS, Vol. 1615-9853, Iss. 19, 2015-10 ,pp. : 3361-3369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic Determinants of Antibody Levels in Cerebrospinal Fluid in Multiple Sclerosis: Possible Links to Endogenous Retroviruses

By Emmer Alexander   Brütting Christine   Kornhuber Malte   Staege Martin S.  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 786-786

MDPI

Access to resources Recommend Favorite

Decreased levels of alpha‐synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis

By  

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 134, Iss. 4, 2015-08 ,pp. : 748-755

John Wiley & Sons Inc

Access to resources Recommend Favorite

Decrease in Asymmetrical Dimethylarginine, an Endogenous Nitric Oxide Synthase Inhibitor, in Cerebrospinal Fluid during Elderly Aging and in Patients with Sporadic Form of Amyotrophic Lateral Sclerosis

By  

Neurosignals, Vol. 18, Iss. 1, 2010-04 ,pp. : 43-48

Karger

Access to resources Recommend Favorite

Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach

By Colomba Paolo   Fontana Simona   Salemi Giuseppe   Barranca Marilisa   Lo Sicco Claudia   Mazzola Maria Antonietta   Ragonese Paolo   Savettieri Giovanni   De Leo Giacomo   Alessandro Riccardo   Duro Giovanni  

International Journal of Molecular Sciences, Vol. 15, Iss. 12, 2014-12 ,pp. : 23269-23282

MDPI

Access to resources Recommend Favorite